Factors Responsible for Obesity-Related Hypertension

Current Hypertension Reports

Volumn 19, Issue 7, 2017, Pages

  Lim, Kyungjoon ^a,b,c   Jackson, Kristy L ^b   Sata, Yusuke ^b,c   Head, Geoffrey A ^b,c  

^a LA TROBE UNIVERSITY   (Australia)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^c MONASH UNIVERSITY   (Australia)

Author keywords

Aversive stress; Blood pressure; Central nervous system; High fat diet; Hypertension; Hypothalamus; Insulin; Leptin; Obesity; Sympathetic nervous system

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; LEPTIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MELANOCORTIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; N ACETYL ALPHA INTERMEDIN[4-10]CYCLO[4 NORLEUCINE 5 ASPARTIC ACID 7 [3 (2 NAPHTHYL)ALANINE] 10 LYSINAMIDE]; NEUROPEPTIDE Y; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOLIPASE C GAMMA; STAT3 PROTEIN; TUMOR NECROSIS FACTOR;

ADRENERGIC TRANSMISSION; ANTIHYPERTENSIVE ACTIVITY; ENZYME ACTIVATION; ENZYME INHIBITION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERPHAGIA; HYPERTENSION; HYPOTHALAMUS; LIPID DIET; NERVE CELL PLASTICITY; NONHUMAN; OBESITY; OBESITY RELATED HYPERTENSION; PROTEIN BINDING; REVIEW; SIGNAL TRANSDUCTION; ADRENERGIC SYSTEM; ANIMAL; COMPLICATION; METABOLISM; PATHOPHYSIOLOGY; RISK FACTOR;

ANIMALS; HUMANS; HYPERTENSION; HYPOTHALAMUS; LEPTIN; OBESITY; RISK FACTORS; SIGNAL TRANSDUCTION; SYMPATHETIC NERVOUS SYSTEM;

EID: 85020047616     PISSN: 15226417     EISSN: 15343111     Source Type: Journal    
DOI: 10.1007/s11906-017-0750-1     Document Type: Review

References (102)

1. Alwan A, World Health Organization. Global Status Report on Noncommunicable Diseases 2010. 2010.
2. Head G. Cardiovascular and metabolic consequences of obesity. Front Physiol. 2015;6(32):1–3.
3. Dzau VJ. Atherosclerosis and hypertension: mechanisms and interrelationships. J Cardiovasc Pharmacol. 1990;15(Suppl 5):S59–64.
4. Esler M, Jennings G, Korner P, Willett I, Dudley F, Hasking G, et al. Assessment of human sympathetic nervous system activity from measurements of norepinephrine turnover. Hypertension. 1988;11:3–20.
5. Head GA, Lim K, Barzel B, Burke SL, Davern PJ. Central nervous system dysfunction in obesity induced hypertension. Curr Hypertens Rep. 2014;16(9):466–74.
6. Case AJ, Zimmerman MC. Sympathetic-mediated activation versus suppression of the immune system: consequences for hypertension. J Physiol. 2016;594(3):527–36.
7. Rumantir MS, Vaz M, Jennings GL, Collier G, Kaye DM, Seals DR, et al. Neural mechanisms in human obesity-related hypertension. J Hypertens. 1999;17(8):1125–33.
8. Davy KP, Hall JE. Obesity and hypertension: two epidemics or one? Am J Physiol Regul Integr Comp Physiol. 2004;286(5):R803–R13.
9. Robles RG, Villa E, Santirso R, Martinez J, Ruilope LM, Cuesta C, et al. Effects of captopril on sympathetic activity, lipid and carbohydrate metabolism in a model of obesity-induced hypertension in dogs. Am J Hypertens. 1993;6(12):1009–15.
10. Hall JE. Mechanisms of abnormal renal sodium handling in obesity hypertension. Am J Hypertens. 1997;10(5 Pt 2):49S–55S.
11. da Silva AA, do Carmo J, Dubinion J, Hall JE. The role of the sympathetic nervous system in obesity-related hypertension. Curr Hypertens Rep. 2009;11(3):206–11.
12. Vaz M, Jennings G, Turner A, Cox H, Lambert G, Esler M. Regional sympathetic nervous activity and oxygen consumption in obese normotensive human subjects. Circulation. 1997;96(10):3423–9.
13. Kalil GZ, Haynes WG. Sympathetic nervous system in obesity-related hypertension: mechanisms and clinical implications. Hypertens Res. 2012;35(1):4–16.
14. Lambert E, Straznicky N, Schlaich M, Esler M, Dawood T, Hotchkin E, et al. Differing pattern of sympathoexcitation in normal-weight and obesity-related hypertension. Hypertension. 2007;50(5):862–8.
15. Lambert E, Straznicky N, Eikelis N, Esler M, Dawood T, Masuo K, et al. Gender differences in sympathetic nervous activity: influence of body mass and blood pressure. J Hypertens. 2007;25(7):1411–9.
16. Alvarez GE, Beske SD, Ballard TP, Davy KP. Sympathetic neural activation in visceral obesity. Circulation. 2002;106(20):2533–6.
17. Straznicky NE, Lambert EA, Grima MT, Eikelis N, Richards K, Nestel PJ, et al. The effects of dietary weight loss on indices of norepinephrine turnover: modulatory influence of hyperinsulinemia. Obesity (Silver Spring). 2014;22(3):652–62.
18. Lambert EA, Rice T, Eikelis N, Straznicky NE, Lambert GW, Head GA, et al. Sympathetic activity and cardiovascular risk in non-diabetic severely obese patients: the effect of 10% weight loss. Am J Hypertens. 2014;27(10):1308–15.
19. Kassab S, Kato T, Wilkins FC, Chen R, Hall JE, Granger JP. Renal denervation attenuates the sodium retention and hypertension associated with obesity. Hypertension. 1995;25(4 Pt 2):893–7.
20. Moretti J-L, Burke SL, Evans RG, Lambert GW, Head GA. Enhanced responses to ganglion blockade do not reflect sympathetic nervous system contribution to angiotensin II-induced hypertension. J Hypertens. 2009;27(9):1838–48.
21. Carlson SH, Shelton J, White CR, Wyss JM. Elevated sympathetic activity contributes to hypertension and salt sensitivity in diabetic obese Zucker rats. Hypertension. 2000;35(1 Pt 2):403–8.
22. • Armitage JA, Burke SL, Prior LJ, Barzel B, Eikelis N, Lim K, et al. Rapid onset of renal sympathetic nerve activation in rabbits fed a high-fat diet. Hypertension. 2012;60:163–71. We found that elevated sympathetic drive and impaired baroreflex function which occur within 1 week of rabbits consuming a high-fat, diet is integral to the rapid development of obesity related hypertension due to increased plasma leptin and insulin.
23. Rajapakse N, Karim F, Straznicky N, Fernande S, Evans R, Head G, et al. Augmented endothelial-specific L-arginine transport prevents obesity-induced hypertension. Acta Physiol (Oxf). 2014;212(1):39–48.
24. Shibao C, Gamboa A, Diedrich A, Ertl AC, Chen KY, Byrne DW, et al. Autonomic contribution to blood pressure and metabolism in obesity. Hypertension. 2007;49(1):27–33.
25. Bonaa KH, Thelle DS. Association between blood pressure and serum lipids in a population. The Tromso study. Circulation. 1991;83(4):1305–14.
26. Kannel WB. Lipids, diabetes, and coronary heart disease: insights from the Framingham study. Am Heart J. 1985;110:1100–7.
27. MacMahon SW, Macdonald GJ, Blacket RB. Plasma lipoprotein levels in treated and untreated hypertensive men and women. The National Heart Foundation of Australia Risk Factor Prevalence study. Arteriosclerosis. 1985;5(4):391–6.
28. Paim BA, Velho JA, Castilho RF, Oliveira HC, Vercesi AE. Oxidative stress in hypercholesterolemic LDL (low-density lipoprotein) receptor knockout mice is associated with low content of mitochondrial NADP-linked substrates and is partially reversed by citrate replacement. Free Radic Biol Med. 2008;44(3):444–51.
29. Evangelho JS, Casali KR, Campos C, De Angelis K, Veiga AB, Rigatto K. Hypercholesterolemia magnitude increases sympathetic modulation and coagulation in LDLr knockout mice. Auton Neurosci. 2011;159(1–2):98–103.
30. de Oliveira J, Hort MA, Moreira EL, Glaser V, Ribeiro-do-Valle RM, Prediger RD, et al. Positive correlation between elevated plasma cholesterol levels and cognitive impairments in LDL receptor knockout mice: relevance of cortico-cerebral mitochondrial dysfunction and oxidative stress. Neuroscience. 2011;197:99–106.
31. Nagae A, Fujita M, Kawarazaki H, Matsui H, Ando K, Fujita T. Sympathoexcitation by oxidative stress in the brain mediates arterial pressure elevation in obesity-induced hypertension. Circulation. 2009;119(7):978–86.
32. Campos RR, Oliveira-Sales EB, Nishi EE, Boim MA, Dolnikoff MS, Bergamaschi CT. The role of oxidative stress in renovascular hypertension. Clin Exp Pharmacol Physiol. 2011;38(2):144–52.
33. Oliveira-Sales EB, Nishi EE, Carillo BA, Boim MA, Dolnikoff MS, Bergamaschi CT, et al. Oxidative stress in the sympathetic premotor neurons contributes to sympathetic activation in renovascular hypertension. Am J Hypertens. 2009;22(5):484–92.
34. Fujita M, Ando K, Nagae A, Fujita T. Sympathoexcitation by oxidative stress in the brain mediates arterial pressure elevation in salt-sensitive hypertension. Hypertension. 2007;50(2):360–7.
35. Marques FZ, Campain AE, Davern PJ, Yang YHI, Head GA, Morris BJ. Genes influencing circadian differences in blood pressure in hypertensive mice. PLoS One. 2011;6(4):e19203. 1-9
36. Fujita M, Kuwaki T, Ando K, Fujita T. Sympatho-inhibitory action of endogenous adrenomedullin through inhibition of oxidative stress in the brain. Hypertension. 2005;45(6):1165–72.
37. Nickenig G, Jung O, Strehlow K, Zolk O, Linz W, Scholkens BA, et al. Hypercholesterolemia is associated with enhanced angiotensin AT1-receptor expression. Am J Phys. 1997;272(6 Pt 2):H2701–7.
38. Strehlow K, Wassmann S, Bohm M, Nickenig G. Angiotensin AT1 receptor over-expression in hypercholesterolaemia. Ann Med. 2000;32(6):386–9.
39. Borghi C, Veronesi M, Cosentino E, Cicero AF, Kuria F, Dormi A, et al. Interaction between serum cholesterol levels and the renin-angiotensin system on the new onset of arterial hypertension in subjects with high-normal blood pressure. J Hypertens. 2007;25(10):2051–7.
40. Kishi T, Hirooka Y. Sympathoexcitation associated with renin-angiotensin system in metabolic syndrome. Int J Hypertens. 2013;2013:406897.
41. Millar PJ, Floras JS. Statins and the autonomic nervous system. Clin Sci (Lond). 2014;126(6):401–15.
42. Lambert E, Chatzivlastou K, Schlaich M, Lambert G, Head G. Morning surge in blood pressure is associated with reactivity of the sympathetic nervous system. Am J Hypertens. 2014;27(6):783–92.
43. Head GA, Andrianopoulos N, McGrath BP, Martin CA, Carrington MJ, Lukoshkova EV, et al. Predictors of mean arterial pressure morning rate of rise and power function in subjects undergoing ambulatory blood pressure recording. PLoS One. 2014;9(3):e93186. 1-10
44. Purkayastha S, Zhang H, Zhang G, Ahmed Z, Wang Y, Cai D. Neural dysregulation of peripheral insulin action and blood pressure by brain endoplasmic reticulum stress. Proc Natl Acad Sci U S A. 2011;108(7):2939–44.
45. Purkayastha S, Zhang G, Cai D. Uncoupling the mechanisms of obesity and hypertension by targeting hypothalamic IKK-beta and NF-kappaB. Nat Med. 2011;17(7):883–7.
46. Shi P, Diez-Freire C, Jun JY, Qi Y, Katovich MJ, Li Q, et al. Brain microglial cytokines in neurogenic hypertension. Hypertension. 2010;56(2):297–303.
47. Xue B, Thunhorst RL, Yu Y, Guo F, Beltz TG, Felder RB, et al. Central renin-angiotensin system activation and inflammation induced by high-fat diet sensitize angiotensin II-elicited hypertension. Hypertension. 2016;67(1):163–70.
48. Xue B, Yu Y, Zhang Z, Guo F, Beltz TG, Thunhorst RL, et al. Leptin mediates high-fat diet sensitization of angiotensin II-elicited hypertension by upregulating the brain renin-angiotensin system and inflammation. Hypertension. 2016;67(5):970–6.
49. Eikelis N, Lambert G, Wiesner G, Kaye D, Schlaich M, Morris M, et al. Extra-adipocyte leptin release in human obesity and its relation to sympathoadrenal function. Am J Physiol Endocrinol Metab. 2004;286(5):E744–52.
50. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med. 1996;334(5):292–5.
51. Lambert E, Straznicky N, Sari CK, Eikelis N, Hering D, Head GA, et al. Dyslipidemia is associated with sympathetic nervous activation and impaired endothelial function in young females. Am J Hypertens. 2013;26(2):250–6.
52. Matsumura K, Abe I, Tsuchihashi T, Fujishima M. Central effects of leptin on cardiovascular and neurohormonal responses in conscious rabbits. Am J Physiol Regul Integr Comp Physiol. 2000;278(5):R1314–R20.
53. Dunbar JC, Hu Y, Lu H. Intracerebroventricular leptin increases lumbar and renal sympathetic nerve activity and blood pressure in normal rats. Diabetes. 1997;46(12):2040–3.
54. Haynes WG, Morgan DA, Walsh SA, Mark AL, Sivitz WI. Receptor-mediated regional sympathetic nerve activation by leptin. J Clin Invest. 1997;100(2):270–8.
55. Shek EW, Brands MW, Hall JE. Chronic leptin infusion increases arterial pressure. Hypertension. 1998;31(1 Pt 2):409–14.
56. Carlyle M, Jones OB, Kuo JJ, Hall JE. Chronic cardiovascular and renal actions of leptin: role of adrenergic activity. Hypertension. 2002;39(2 Pt 2):496–501.
57. Baltatzi M, Hatzitolios A, Tziomalos K, Iliadis F, Zamboulis C. Neuropeptide Y and alpha-melanocyte-stimulating hormone: interaction in obesity and possible role in the development of hypertension. Int J Clin Pract. 2008;62(9):1432–40.
58. Williams G, Bing C, Cai XJ, Harrold JA, King PJ, Liu XH. The hypothalamus and the control of energy homeostasis: different circuits, different purposes. Physiol Behav. 2001;74(4–5):683–701.
59. do Carmo JM, da Silva AA, Cai Z, Lin S, Dubinion JH, Hall JE. Control of blood pressure, appetite, and glucose by leptin in mice lacking leptin receptors in proopiomelanocortin neurons. Hypertension. 2011;57(5):918–26.
60. Tallam LS, da Silva AA, Hall JE. Melanocortin-4 receptor mediates chronic cardiovascular and metabolic actions of leptin. Hypertension. 2006;48(1):58–64.
61. Harlan SM, Rahmouni K. PI3K signaling: a key pathway in the control of sympathetic traffic and arterial pressure by leptin. Mol Metab. 2013;2(2):69–73.
62. Harlan SM, Guo DF, Morgan DA, Fernandes-Santos C, Rahmouni K. Hypothalamic mTORC1 signaling controls sympathetic nerve activity and arterial pressure and mediates leptin effects. Cell Metab. 2013;17(4):599–606.
63. Minokoshi Y, Alquier T, Furukawa N, Kim YB, Lee A, Xue B, et al. AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus. Nature. 2004;428(6982):569–74.
64. Tanida M, Yamamoto N, Morgan DA, Kurata Y, Shibamoto T, Rahmouni K. Leptin receptor signaling in the hypothalamus regulates hepatic autonomic nerve activity via phosphatidylinositol 3-kinase and AMP-activated protein kinase. J Neurosci. 2015;35(2):474–84.
65. Shi Z, Brooks VL. Leptin differentially increases sympathetic nerve activity and its baroreflex regulation in female rats: role of oestrogen. J Physiol. 2015;593(7):1633–47.
66. Burke SL, Head GA. Method for in vivo calibration of renal sympathetic nerve activity in rabbits. J Neurosci Meth. 2003;127:63–74.
67. • Prior L, Eikelis N, Armitage J, Davern P, Burke S, Montani J-P, et al. Exposure to a high-fat diet alters leptin sensitivity and elevates renal sympathetic nerve activity and arterial pressure in rabbits. Hypertension. 2010;55(4):862–8. We provided the first direct evidence that renal sympathetic outflow is elevated in response to high-fat feeding and increased visceral fat deposits and that a marked facilitation of the central sympathoexcitatory responses to leptin likely obesity-hypertension.
68. Barzel B, Weir J, Meikle P, Burke SL, Armitage J, Head GA. Short term fat feeding rapidly increases plasma insulin but does not result in dyslipidaemia. Front Physiol. 2014;5(469):1–8.
69. Burke SL, Prior LJ, Lukoshkova EV, Lim K, Barzel B, Davern P, et al. Reduced preprandial dipping accounts for rapid elevation of blood pressure and renal sympathetic nerve activity in rabbits fed a high-fat diet. Chronobiol Int. 2013;30(5):726–38.
70. Barzel B, Lim K, Burke SL, Armitage J, Head GA. Specific role of dietary fat in modifying cardiovascular and locomotor activity 24h rhythms. Chronobiol Int. 2015;32(5):668–76.
71. •• Lim K, Burke SL, Head GA. Obesity related hypertension and the role of insulin and leptin in high fat fed rabbits. Hypertension. 2013;61(3):628–34. This study used central administration of selective leptin and insulin antagonists to show that the hypertension and elevated renal sympathetic activity induced by a high fat diet for several weeks are predominantly mediated by central sympathoexcitatory actions of the hormone leptin.
72. Barzel B, Lim K, Davern PJ, Burke SL, Armitage JA, Head GA. Central pro-opiomelanocortin but not neuropeptide Y mediates sympatho-excitation and hypertension in fat fed conscious rabbits. J Hypertens. 2016;34(3):464–73.
73. Mark AL, Correia ML, Rahmouni K, Haynes WG. Selective leptin resistance: a new concept in leptin physiology with cardiovascular implications. J Hypertens. 2002;20(7):1245–50.
74. do Carmo JM, da Silva AA, Hall JE. Role of hindbrain melanocortin-4 receptor activity in controlling cardiovascular and metabolic functions in spontaneously hypertensive rats. J Hypertens. 2015;33(6):1201–6.
75. da Silva AA, do Carmo JM, Kanyicska B, Dubinion J, Brandon E, Hall JE. Endogenous melanocortin system activity contributes to the elevated arterial pressure in spontaneously hypertensive rats. Hypertension. 2008;51(4):884–90.
76. Marsh AJ, Fontes MA, Killinger S, Pawlak DB, Polson JW, Dampney RA. Cardiovascular responses evoked by leptin acting on neurons in the ventromedial and dorsomedial hypothalamus. Hypertension. 2003;42(4):488–93.
77. Young CN, Morgan DA, Butler SD, Mark AL, Davisson RL. The brain subfornical organ mediates leptin-induced increases in renal sympathetic activity but not its metabolic effects. Hypertension. 2013;61(3):737–44.
78. Simonds SE, Pryor JT, Ravussin E, Greenway FL, Dileone R, Allen AM, et al. Leptin mediates the increase in blood pressure associated with obesity. Cell. 2014;159(6):1404–16.
79. Elmquist JK, Bjorbaek C, Ahima RS, Flier JS, Saper CB. Distributions of leptin receptor mRNA isoforms in the rat brain. J Comp Neurol. 1998;395(4):535–47.
80. Dahlof B, Sever PS, Poulter NR, Wedel H, Beevers DG, Caulfield M, et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian cardiac outcomes trial-blood pressure lowering arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet. 2005;366(9489):895–906.
81. Vander Tuig JG, Knehans AW, Romsos DR. Reduced sympathetic nervous system activity in rats with ventromedial hypothalamic lesions. Life Sci. 1982;30(11):913–20.
82. Harlan SM, Morgan DA, Agassandian K, Guo DF, Cassell MD, Sigmund CD, et al. Ablation of the leptin receptor in the hypothalamic arcuate nucleus abrogates leptin-induced sympathetic activation. Circ Res. 2011;108(7):808–12.
83. Qi Y, Henry BA, Oldfield BJ, Clarke IJ. The action of leptin on appetite-regulating cells in the ovine hypothalamus: demonstration of direct action in the absence of the arcuate nucleus. Endocrinology. 2010;151(5):2106–16.
84. Ambati S, Duan J, Choi YH, Hartzell DL, Della-Fera MA, Baile CA. ICV vs. VMH injection of leptin: comparative effects on hypothalamic gene expression. Behav Brain Res. 2009;196(2):279–85.
85. Lindberg D, Chen P, Li C. Conditional viral tracing reveals that steroidogenic factor 1-positive neurons of the dorsomedial subdivision of the ventromedial hypothalamus project to autonomic centers of the hypothalamus and hindbrain. J Comp Neurol. 2013;521(14):3167–90.
86. Lim K, Barzel B, Burke S, Armitage J, Head G. The origin of aberrant blood pressure and sympathetic regulation in diet induced obesity. Hypertension. 2016;68(2):491–500.
87. Montanaro MS, Allen AM, Oldfield BJ. Structural and functional evidence supporting a role for leptin in central neural pathways influencing blood pressure in rats. Exp Physiol. 2005;90(5):689–96.
88. Prior L, Davern P, Burke S, Lim K, Armitage J, Head G. Exposure to a high fat diet during development alters leptin and ghrelin sensitivity and elevates renal sympathetic nerve activity and arterial pressure in rabbits. Hypertension. 2014;63(2):338–45.
89. Rahmouni K, Correia ML, Haynes WG, Mark AL. Obesity-associated hypertension: new insights into mechanisms. Hypertension. 2005;45(1):9–14.
90. Horvath TL. Synaptic plasticity mediating leptin’s effect on metabolism. Prog Brain Res. 2006;153:47–55.
91. Irving AJ, Wallace L, Durakoglugil D, Harvey J. Leptin enhances NR2B-mediated N-methyl-D-aspartate responses via a mitogen-activated protein kinase-dependent process in cerebellar granule cells. Neuroscience. 2006;138(4):1137–48.
92. Pinto S, Roseberry AG, Liu H, Diano S, Shanabrough M, Cai X, et al. Rapid rewiring of arcuate nucleus feeding circuits by leptin. Science. 2004;304(5667):110–5.
93. Nuzzaci D, Laderriere A, Lemoine A, Nedelec E, Penicaud L, Rigault C, et al. Plasticity of the melanocortin system: determinants and possible consequences on food intake. Front Endocrinol (Lausanne). 2015;6:143.
94. Toda C, Shiuchi T, Kageyama H, Okamoto S, Coutinho EA, Sato T, et al. Extracellular signal-regulated kinase in the ventromedial hypothalamus mediates leptin-induced glucose uptake in red-type skeletal muscle. Diabetes. 2013;62(7):2295–307.
95. Marosi K, Mattson MP. BDNF mediates adaptive brain and body responses to energetic challenges. Trends Endocrinol Metab. 2014;25(2):89–98.
96. Huang EJ, Reichardt LF. Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci. 2001;24:677–736.
97. Xu B, Goulding EH, Zang K, Cepoi D, Cone RD, Jones KR, et al. Brain-derived neurotrophic factor regulates energy balance downstream of melanocortin-4 receptor. Nat Neurosci. 2003;6(7):736–42.
98. Caruso V, Lagerstrom MC, Olszewski PK, Fredriksson R, Schioth HB. Synaptic changes induced by melanocortin signalling. Nat Rev Neurosci. 2014;15(2):98–110.
99. Unger TJ, Calderon GA, Bradley LC, Sena-Esteves M, Rios M. Selective deletion of BDNF in the ventromedial and dorsomedial hypothalamus of adult mice results in hyperphagic behavior and obesity. J Neurosci. 2007;27(52):14265–74.
100. Rios M. BDNF and the central control of feeding: accidental bystander or essential player? Trends Neurosci. 2013;36(2):83–90.
101. Cone RD. Anatomy and regulation of the central melanocortin system. Nat Neurosci. 2005;8(5):571–8.
102. Bariohay B, Roux J, Tardivel C, Trouslard J, Jean A, Lebrun B. Brain-derived neurotrophic factor/tropomyosin-related kinase receptor type B signaling is a downstream effector of the brainstem melanocortin system in food intake control. Endocrinology. 2009;150(6):2646–53.